PROV REGL MED CENTER EVERETT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $11.2M
- Transactions
- 966
- Companies
- 40
- Average per transaction
- $11,618
Who reported the payments
| Gilead | $2,824,818 |
| Hoffmann-la Roche Limited | $2,253,378 |
| Boston Scientific | $902,646 |
| Merck | $821,714 |
| Regeneron | $704,245 |
| Novartis | $612,373 |
| Boehringer Ingelheim | $416,166 |
| Cardiovascular Systems Inc. | $368,641 |
| AstraZeneca | $299,025 |
| Purdue Pharma L.p. | $258,762 |
| Seagen Inc. | $245,306 |
| Pfizer | $228,563 |
| Abbott | $150,662 |
| Janssen Research & Development, LLC | $136,099 |
| Genentech, Inc. | $126,773 |
| E.r. Squibb & Sons, L.L.C. | $114,706 |
| Smith+Nephew | $110,333 |
| AbbVie | $95,353 |
| Incyte Corporation | $71,223 |
| Roche Products Limited | $63,488 |
| Bristol Myers Squibb | $53,177 |
| F. Hoffmann-la Roche AG | $47,330 |
| Amgen | $38,551 |
| EMD Serono, Inc. | $36,262 |
| Astrazeneca UK Limited | $32,377 |
| Mirati Therapeutics, Inc. | $22,519 |
| Karyopharm Therapeutics Inc. | $19,541 |
| CSL Behring | $18,169 |
| Eli Lilly | $16,428 |
| Pharmacyclics LLC, An Abbvie Company | $14,978 |
| Sanofi Pasteur Inc. | $14,000 |
| Stryker | $13,531 |
| Viiv Healthcare Company | $12,000 |
| Astellas Pharma US Inc | $11,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,500 |
| GSK | $6,500 |
| Johnson & Johnson | $6,500 |
| Indivior Inc. | $5,500 |
| La Jolla Pharmaceutical Company | $5,500 |
| Insmed, Inc. | $5,500 |